#antimicrobial-resistance

#antimicrobial-resistance

Over three million children died from antibiotic-resistant infections in 2022, highlighting the urgent need for strategies to combat antimicrobial resistance.

Antimicrobial resistance could revert us to a pre-antibiotic era, posing threats to global health.

Dr. Sylvia Omulo's research on harmless microbes offers insights for combating AMR.

Fungal pathogens require innovative science and policy solutions to address their growing threat.

Over 39 million deaths anticipated from antibiotic-resistant infections by 2050, significantly affecting older populations.

AMR poses a significant threat to modern medicine by potentially making common infections deadly.

Antimicrobial resistance threatens global health, potentially causing millions of preventable deaths unless immediate action is taken.

The overuse of antibiotics has led to the rapid evolution of superbugs, resulting in potentially millions of deaths by 2050 without action.

Antimicrobial resistance poses a serious global health threat, endangering routine medical procedures and leading to rising mortality rates, especially among the elderly.

Wild birds in urban areas carry antibiotic-resistant bacteria, posing health risks to humans and livestock.

Research highlights the connection between antimicrobial resistance in urban wildlife and potential impacts on public health.

Flies in hospitals may spread drug-resistant bacteria among patients, posing a serious health risk.

Antimicrobial resistance (AMR) is projected to become a major global health crisis, with millions of deaths by 2050.

Drug-resistant infections may cause 2 million deaths annually by 2050, with the majority being older adults.

Wider access to effective antibiotics could save 92 million lives from 2025 to 2050.

Overuse of antibiotics during the COVID-19 pandemic has led to concerns about breeding superbugs and antimicrobial resistance.

A protein in Australian oysters may combat superbugs and enhance antibiotic effectiveness.

Bacteriophage therapy is a viable alternative to antibiotics, especially with rising antibiotic resistance.

The discovery of penicillin and the narrative of antibiotics is both dramatic and urgent, reflecting the ongoing battle against antimicrobial resistance.

Stanton Williams will design the Fleming Centre, focusing on combating antimicrobial resistance through collaboration and innovation.

Pivmecillinam, a new antibiotic approved by the FDA for UTIs, offers a crucial solution for the increasing resistance to existing antimicrobial drugs.